Article
[Immune-mediated thrombotic thrombocytopenic purpura and susceptible HLA alleles].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2022
Sakai Kazuya
Abstract excerpt
Thrombotic thrombocytopenic purpura (TTP) is an extremely rare and fatal thrombotic disorder characterized by impaired enzyme activity of von Willebrand factor cleaving protease, also known as ADAMTS13. Immune-mediated TTP (iTTP) is an acquired form of TTP caused by the production of auto-antibodies against ADAMTS13. The pathophysiology of autoimmune disorders is multifactorial, with several human leukocyte...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
